Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Eterna Therapeutics (ERNA) Stock Price & Analysis

ERNA Stock Chart & Stats

$1.95-$0.02(-0.90%)
At close: 10:23 AM EST
$2$3$4$510 Aug24 Aug8 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
$1.93 - $2.04
52-Week Range
$1.84 - $47.25
Previous Close
$1.97
Volume
N/A
Average Volume (3M)
51.53K
Market Cap
$3.22M
Enterprise Value
-$6.94T
Total Cash (Recent Filing)
$5.03M
Total Debt (Recent Filing)
$349.00K
Price to Earnings (P/E)
―
Beta
1.97
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Eterna Therapeutics News

ERNA FAQ

What was Eterna Therapeutics’s price range in the past 12 months?
Eterna Therapeutics lowest stock price was $1.84 and its highest was $47.25 in the past 12 months.
What is Eterna Therapeutics’s market cap?
Eterna Therapeutics’s market cap is $3.22M.
When is Eterna Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eterna Therapeutics’s earnings last quarter?
Eterna Therapeutics released its earnings results on Apr 14, 2023. The company reported -$1.24 earnings per share for the quarter, beating the consensus estimate of -$2.4 by $1.16.
Is Eterna Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Eterna Therapeutics pay dividends?
Eterna Therapeutics does not currently pay dividends.
What is Eterna Therapeutics’s EPS estimate?
Eterna Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eterna Therapeutics have?
Eterna Therapeutics has 1,632,411 shares outstanding.
What happened to Eterna Therapeutics’s price movement after its last earnings report?
Eterna Therapeutics reported an EPS of -$1.24 in its last earnings report, beating expectations of -$2.4. Following the earnings report the stock price went up 3.67%.
Which hedge fund is a major shareholder of Eterna Therapeutics?
Hedge funds hold Eterna Therapeutics shares: the largest hedge-fund position in Eterna Therapeutics is 71,883,249 shares.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology